Shares of ENDRA Life Sciences Inc (NASDAQ:NDRA) traded down 20.8% during mid-day trading on Thursday . The stock traded as low as $2.27 and last traded at $2.32. 967,206 shares changed hands during trading, an increase of 491% from the average session volume of 163,696 shares. The stock had previously closed at $2.93.
ENDRA Life Sciences (NASDAQ:NDRA) last posted its quarterly earnings data on Monday, November 5th. The company reported ($0.63) earnings per share (EPS) for the quarter. ENDRA Life Sciences had a negative return on equity of 394.07% and a negative net margin of 114.33%.
In related news, major shareholder Longboard Capital Advisors, Ll sold 130,200 shares of the stock in a transaction that occurred on Wednesday, October 24th. The stock was sold at an average price of $4.19, for a total value of $545,538.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 12.70% of the company’s stock.
ENDRA Life Sciences Company Profile (NASDAQ:NDRA)
ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding.
Featured Story: Outstanding Shares
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.